Pascal Biosciences confirmed specific cannabinoids combat Coronavirus
On Sept. 23, 2020, Pascal Biosciences announced the Company had confirmed an earlier report that certain cannabinoids block…
Pascal Biosciences and SoRSE Technology announced partnership for cannabinoid drug development and cancer clinical trials
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
Pascal Biosciences commenced cannabinoid testing of human volunteers and patients
On Jan. 24, 2019, Pascal Biosciences announced the testing of cannabinoids in human subjects for its immune stimulatory…
Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
The first cannabinoid receptor was documented
In 1986, scientists independently identified the structure of a nerve cell receptor, now called CB1, which responded to…